SCHEMBL13403232

SCHEMBL13403232

[C-]#[N+]/C=C/c1cccc(/C=C/C(=O)c2c(OC)cc(C)oc2=O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.56
MEN1 O00255 6/20 0.56
KMT2A Q03164 6/20 0.56
KDM4E B2RXH2 2/20 0.56
RECQL P46063 2/20 0.53
GAA P10253 1/20 0.53
HTT P42858 1/20 0.53
NPSR1 Q6W5P4 4/20 0.52
POLB P06746 2/20 0.52
RAB9A P51151 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
PLIN1 O60240 1/20 0.52
ALOX12 P18054 1/20 0.52
PLIN5 Q00G26 1/20 0.52
ABHD5 Q8WTS1 1/20 0.52
USP2 O75604 2/20 0.49
NPC1 O15118 1/20 0.47
PKM P14618 1/20 0.47
NQO1 P15559 2/20 0.46
TXNRD1 Q16881 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13403231 0.86 MAPT (0.66) MAPTMEN1KMT2AKDM4ERECQL
SCHEMBL15233113 0.85 MAPT (0.61) MAPTMEN1KMT2AKDM4ERECQL
SCHEMBL3528426 0.84 MAPT (0.57) MAPTMEN1KMT2AKDM4ERECQL
SCHEMBL3528423 0.84 MAPT (0.57) MAPTMEN1KMT2AKDM4ERECQL
SCHEMBL3525167 0.83 MAPT (0.56) MAPTMEN1KMT2AKDM4ERECQL
SCHEMBL3525166 0.83 MAPT (0.56) MAPTMEN1KMT2AKDM4ERECQL
SCHEMBL3529088 0.78 MAPT (0.53) MAPTMEN1KMT2AKDM4ERECQL
SCHEMBL5631165 0.78 MAPT (0.53) MAPTMEN1KMT2AKDM4ERECQL
SCHEMBL5631167 0.78 MAPT (0.53) MAPTMEN1KMT2AKDM4ERECQL
SCHEMBL3528360 0.78 MEN1 (0.53) MAPTMEN1KMT2AKDM4ERECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691883-B2 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-06 US disclosed
US-20070265228-A1 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265228-A1 Cinnamoyl compound and use of the same NPC1, CES2, CYP51A1 MAPT 2195/4885MEN1 876/4885KMT2A 3443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.